Literature DB >> 2917585

The relationship between theophylline clearance and age in adult life.

S H Jackson1, A Johnston, R Woollard, P Turner.   

Abstract

Fifty three subjects (31 normal volunteers and 22 patients with asthma) between the ages of 20 and 87 years had their theophylline clearance measured. Volume of distribution (V) and terminal elimination half-life (t1/2) were also calculated in the volunteers who received i.v. theophylline. Although patients tended to have higher clearance values than volunteers, in both groups the oldest third had the lowest clearances. For the combined group (corrected for the patient effect) the oldest third (mean age 70 years) had a mean clearance of 0.53 versus 0.72 for the middle third (mean age 47 years) and 0.73 ml/min/kg CBW for the youngest third (mean age 26 years). There was no statistically significant age related change in V/kg CBW but t1/2 did rise with increasing age. Thus, although clearance does not fall with increasing age during younger adult life, there is a fall during late adult life becoming apparent in the seventh, eighth and ninth decades.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917585     DOI: 10.1007/BF00561019

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Pharmacokinetics of theophylline in ten elderly patients.

Authors:  F Nielsen-Kudsk; I Magnussen; P Jakobsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-03

2.  Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

Authors:  A Rodgers; K W Woodhouse; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

3.  The relation of product formulation to absorption of oral theophylline.

Authors:  M Weinberger; L Hendeles; L Bighley
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

4.  STRIPE: an interactive computer program for the analysis of drug pharmacokinetics.

Authors:  A Johnston; R C Woollard
Journal:  J Pharmacol Methods       Date:  1983-05

5.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

6.  Homogeneous enzyme immunoassay for theophylline in serum and plasma.

Authors:  J Chang; S Gotcher; J B Gushaw
Journal:  Clin Chem       Date:  1982-02       Impact factor: 8.327

7.  Effect of age on patterns of theophylline metabolism.

Authors:  J J Grygiel; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

8.  Theophylline kinetics in a geriatric group.

Authors:  R W Fox; S Samaan; S C Bukantz; R F Lockey
Journal:  Clin Pharmacol Ther       Date:  1983-07       Impact factor: 6.875

9.  Theophylline kinetics in relation to age: the importance of smoking.

Authors:  B Cusack; J G Kelly; J Lavan; J Noel; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

10.  Theophylline kinetics in chronic obstructive airway disease in the elderly.

Authors:  W Y Au; A K Dutt; N DeSoyza
Journal:  Clin Pharmacol Ther       Date:  1985-04       Impact factor: 6.875

View more
  6 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Age-related changes in hepatic function. Implications for drug therapy.

Authors:  K Woodhouse; H A Wynne
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

Review 3.  Chronic obstructive pulmonary disease in the elderly: an update on pharmacological management.

Authors:  Amy L Dzierba; Sanja Jelic
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 5.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Caffeine and the elderly.

Authors:  L K Massey
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.